Monsanto hit with $165 million verdict over PCBs in Seattle school
Send a link to a friend
[November 22, 2023]
By Clark Mindock
(Reuters) - A U.S. jury has ordered Bayer's Monsanto to pay $165 million
to employees of a school northeast of Seattle who claimed chemicals made
by the company called polychlorinated biphenyls, or PCBs, leaked from
light fixtures and got them sick.
The Washington state court jury found the company liable for selling
products containing PCBs used in the Sky Valley Education Center in
Monroe, Washington, that were not safe, and did not include adequate
warnings. The award included nearly $50 million in compensatory damages,
and $115 million in punitive damages.
The verdict in favor of six teachers and a custodian who said exposure
to the PCBs gave them cancer, brain injuries and other issues marks the
latest trial loss for the company, which is now facing nearly $870
million in verdicts from alleged PCBs exposure at the Sky Valley center,
said an attorney for the plaintiffs.
The company is appealing those verdicts.
Monsanto said in a statement that it will contest Monday's verdict, and
that blood, air and other tests show the school employees were not
exposed to unsafe levels of PCBs.
PCBs are chemicals once widely used to insulate electrical equipment and
in other common products like carbon copy paper, caulking, floor finish
and paint. The U.S. government outlawed the chemicals in 1979 after
discovering links to cancer.
[to top of second column]
|
The logo of Monsanto is seen at the Monsanto factory in Peyrehorade,
France, August 23, 2019. REUTERS/Stephane Mahe/ File Photo
Employees, students and others have
claimed in numerous lawsuits against the company that exposure to
PCBs at the Sky Valley center caused their cancers, thyroid
conditions and other health problems.
The company said on Monday it stopped producing PCBs in 1977. It
also said the school had been warned repeatedly since the 1990s that
its light fixtures needed to be retrofitted, but those warnings were
ignored.
The lawsuit named Monsanto spinoff Pharmacia as the defendant in the
case, though Monsanto is expected to be required to cover the
damages due to legal agreements between the companies governing
liabilities from historic chemicals production, according to
attorneys for the plaintiffs and financial reports.
(Reporting by Clark Mindock, Editing by Alexia Garamfalvi and
Richard Chang)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |